Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert P Webb

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Toxins|June 9, 2018
Engineering of Botulinum Neurotoxins for Biomedical ApplicationsRobert P Webb
Expert Review of Vaccines|May 11, 2013
What next for botulism vaccine development?Robert P Webb, Leonard A Smith
Vaccine|December 19, 2020
Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc™)Vicki A Montgomery, Changhong Y Lindsey, Leonard A Smith, et al.
Vaccine|May 20, 2009
Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3Robert P Webb, Theresa J Smith, Patrick Wright, et al.
Frontiers in Immunology|March 26, 2026
Editorial: Towards the rapid and systematic assessment of vaccine technologiesJessica Z Kubicek-Sutherland, Benjamin McMahon, Evan Skowronski, et al.
Vaccine|March 31, 2007
Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxinsRobert P Webb, Theresa J Smith, Patrick M Wright, et al.
Toxins|September 5, 2017
Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of BotulismRobert P Webb, Theresa J Smith, Leonard A Smith, et al.
Journal of Ethnopharmacology|July 30, 2016
Utilizing Ayurvedic literature for the identification of novel phytochemical inhibitors of botulinum neurotoxin AChinni Yalamanchili, Vamshi K Manda, Amar G Chittiboyina, et al.
Cell Reports|February 27, 2020
Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum NeurotoxinsKwok-Ho Lam, Jacqueline M Tremblay, Edwin Vazquez-Cintron, et al.
FEBS Letters|December 17, 2011
Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5Suzanne R Kalb, Jakub Baudys, Robert P Webb, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Toxins|June 9, 2018
Engineering of Botulinum Neurotoxins for Biomedical ApplicationsRobert P Webb
Expert Review of Vaccines|May 11, 2013
What next for botulism vaccine development?Robert P Webb, Leonard A Smith
Vaccine|December 19, 2020
Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc™)Vicki A Montgomery, Changhong Y Lindsey, Leonard A Smith, et al.
Vaccine|May 20, 2009
Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3Robert P Webb, Theresa J Smith, Patrick Wright, et al.
Frontiers in Immunology|March 26, 2026
Editorial: Towards the rapid and systematic assessment of vaccine technologiesJessica Z Kubicek-Sutherland, Benjamin McMahon, Evan Skowronski, et al.
Vaccine|March 31, 2007
Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxinsRobert P Webb, Theresa J Smith, Patrick M Wright, et al.
Toxins|September 5, 2017
Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of BotulismRobert P Webb, Theresa J Smith, Leonard A Smith, et al.
Journal of Ethnopharmacology|July 30, 2016
Utilizing Ayurvedic literature for the identification of novel phytochemical inhibitors of botulinum neurotoxin AChinni Yalamanchili, Vamshi K Manda, Amar G Chittiboyina, et al.
Cell Reports|February 27, 2020
Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum NeurotoxinsKwok-Ho Lam, Jacqueline M Tremblay, Edwin Vazquez-Cintron, et al.
FEBS Letters|December 17, 2011
Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5Suzanne R Kalb, Jakub Baudys, Robert P Webb, et al.
Pageof 2